393 related articles for article (PubMed ID: 19443280)
1. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
3. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
4. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
De Marco G; Sordino D; Bruzzese E; Di Caro S; Mambretti D; Tramontano A; Colombo C; Simoni P; Guarino A
Aliment Pharmacol Ther; 2006 Jul; 24(2):387-94. PubMed ID: 16842466
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.
Chen CY; Tsao PN; Chen HL; Chou HC; Hsieh WS; Chang MH
J Pediatr; 2004 Sep; 145(3):317-21. PubMed ID: 15343182
[TBL] [Abstract][Full Text] [Related]
6. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.
Willis TC; Carter BA; Rogers SP; Hawthorne KM; Hicks PD; Abrams SA
JPEN J Parenter Enteral Nutr; 2010; 34(1):32-7. PubMed ID: 19587385
[TBL] [Abstract][Full Text] [Related]
7. Ursodiol in patients with parenteral nutrition-associated cholestasis.
San Luis VA; Btaiche IF
Ann Pharmacother; 2007 Nov; 41(11):1867-72. PubMed ID: 17911205
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
Arslanoglu S; Moro GE; Tauschel HD; Boehm G
J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390
[TBL] [Abstract][Full Text] [Related]
9. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of parenteral nutrition-associated cholestasis with aminosyn PF compared to trophamine.
Wright K; Ernst KD; Gaylord MS; Dawson JP; Burnette TM
J Perinatol; 2003 Sep; 23(6):444-50. PubMed ID: 13679929
[TBL] [Abstract][Full Text] [Related]
11. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
[TBL] [Abstract][Full Text] [Related]
12. Hyperalimentation-induced cholestasis. Increased incidence and severity in premature infants.
Pereira GR; Sherman MS; DiGiacomo J; Ziegler M; Roth K; Jacobowski D
Am J Dis Child; 1981 Sep; 135(9):842-5. PubMed ID: 6792907
[TBL] [Abstract][Full Text] [Related]
13. Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant.
Steinbach M; Clark RH; Kelleher AS; Flores C; White R; Chace DH; Spitzer AR;
J Perinatol; 2008 Feb; 28(2):129-35. PubMed ID: 18059467
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
[TBL] [Abstract][Full Text] [Related]
15. [Parenteral nutrition associated cholestasis in the newborn].
Schwenk RA; Bauer K; Versmold H
Klin Padiatr; 1998; 210(6):381-9. PubMed ID: 9871892
[TBL] [Abstract][Full Text] [Related]
16. [Parenteral nutrition-associated liver disease].
Moreno Villares JM
Nutr Hosp; 2008 May; 23 Suppl 2():25-33. PubMed ID: 18714408
[TBL] [Abstract][Full Text] [Related]
17. Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.
Mangalat N; Bell C; Graves A; Imseis EM
BMC Pediatr; 2014 Dec; 14():298. PubMed ID: 25492029
[TBL] [Abstract][Full Text] [Related]
18. Aminosyn PF or trophamine: which provides more protection from cholestasis associated with total parenteral nutrition?
Forchielli ML; Gura KM; Sandler R; Lo C
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):374-82. PubMed ID: 8583287
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
[TBL] [Abstract][Full Text] [Related]
20. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
